for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AstraZeneca says its antibody treatment failed in preventing COVID-19 in exposed patients

June 15 (Reuters) - AstraZeneca said on Tuesday its study of monoclonal antibody AZD7442 did not meet the main goal of preventing symptomatic COVID-19 in people recently exposed to the SARS-CoV-2 virus. (Reporting by Vishwadha Chander in Bengaluru; Editing by Shounak Dasgupta)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up